High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes

Diabetes Care

Volumn 34, Issue 8, 2011, Pages 1860-1862

  Mcdonald, Tim J ^a,b   Shields, Beverley M ^a   Lawry, Jane ^b   Owen, Katharine R ^c,d   Gloyn, Anna L ^c,d   Ellard, Sian ^a,b   Hattersley, Andrew T ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA;

ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC SCREENING; HEPATOCYTE NUCLEAR FACTOR 4 ALPHA GENE; HEPATOCYTE NUCLEAR FACTOR 4 BETA GENE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; MUTATOR GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADULT; BLOOD; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MUTATION;

ADULT; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 80054845457     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0323     Document Type: Article

References (12)

1. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51:546-553
2. Lambert AP, Ellard S, Allen LI, et al. Identifying hepatic nuclear factor 1-α mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003;26:333-337 (Pubitemid 36929051)
3. Reiner AP, Barber MJ, Guan Y, et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008;82:1193-1201
4. Ridker PM, Pare G, Parker A, et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008;82:1185-1192
5. Owen KR, Thanabalasingham G, James TJ, et al. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 2010;33:1919-1924
6. Lee CC, Adler AI, Sandhu MS, et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and metaanalysis. Diabetologia 2009;52:1040-1047
7. Shepherd M, Ellis I, Ahmad AM, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med 2001;18:417-421 (Pubitemid 32679393)
8. Besser REJ, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 2011;34:286-291
9. Toniatti C, Demartis A, Monaci P, Nicosia A, Ciliberto G. Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J 1990;9:4467-4475 (Pubitemid 120026004)
10. Mora S, Musunuru K, Blumenthal RS. The clinical utility of high-sensitivity Creactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem 2009;55:219-228
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979 (Pubitemid 27152782)
12. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002;112:269-274 (Pubitemid 34219439)